Melanotan 2 (MT-2): Melanocortin Research Guide

Melanotan 2 (MT-2) is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (α-MSH) originally developed at the University of Arizona in the early 1990s. The compound was designed to activate melanocortin receptors, a family of five G protein-coupled receptors (MC1R through MC5R) that regulate diverse physiological processes including pigmentation, energy homeostasis, inflammation, and sexual function.

MT-2’s broad receptor activity profile — particularly its agonism at MC1R, MC3R, MC4R, and MC5R — has made it one of the most frequently studied melanocortin peptides in preclinical and early-phase research. This guide provides researchers with a comprehensive overview of MT-2’s pharmacology, mechanism, and research applications.

Molecular Structure

MT-2 has the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2 and a molecular weight of 1,024.18 g/mol. Several structural features distinguish it from the native α-MSH tridecapeptide:

• •Cyclic structure — A lactam bridge between the Asp and Lys side chains constrains the peptide into a cyclic conformation, increasing receptor binding affinity and resistance to enzymatic degradation.
• •D-Phenylalanine substitution — Replacement of the natural L-Phe with D-Phe at position 7 enhances metabolic stability and receptor selectivity.
• •Norleucine substitution — Methionine is replaced with norleucine at position 4 to prevent oxidation, a common degradation pathway for methionine-containing peptides.
• •N-terminal acetylation and C-terminal amidation — These terminal modifications protect against exopeptidase degradation and improve receptor binding.

These modifications collectively give MT-2 a significantly longer half-life than native α-MSH (which is degraded within minutes in vivo) while maintaining the core His-Phe-Arg-Trp pharmacophore essential for melanocortin receptor activation.

Melanogenesis & MC1R Signaling

The primary pathway through which MT-2 influences pigmentation is the MC1R signaling cascade in melanocytes. Upon binding to MC1R on the surface of epidermal melanocytes, the following intracellular events are initiated:

Broader Melanocortin Receptor Activity

While MC1R activation drives MT-2’s pigmentation effects, the compound’s non-selective melanocortin agonism produces activity at multiple receptor subtypes:

• •MC3R — Expressed in the hypothalamus and peripheral tissues, MC3R is involved in energy homeostasis and nutrient partitioning. Activation has been associated with modulation of food intake and metabolic efficiency in preclinical models.
• •MC4R — The primary melanocortin receptor in the central nervous system for appetite regulation and energy balance. MT-2’s MC4R agonism has been studied in the context of appetite suppression and sexual function, as this receptor mediates central erectile signaling.
• •MC5R — Found in sebaceous glands and exocrine tissues, MC5R activation influences lipid secretion and has been studied in the context of sebum production and exocrine gland function.

MT-2 vs. PT-141 (Bremelanotide)

PT-141 (Bremelanotide) is a metabolite and analog of MT-2, developed specifically to isolate the MC4R-mediated effects without the pigmentation activity associated with MC1R agonism. Key differences include:

• •Structure — PT-141 is the active cyclic metabolite of MT-2 (Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH), differing by a C-terminal free acid instead of amide.
• •Receptor selectivity — PT-141 shows relatively higher MC4R selectivity with reduced MC1R activity compared to MT-2, resulting in less pigmentation effect.
• •Research focus — PT-141 research has centered primarily on MC4R-mediated central nervous system effects, while MT-2 research spans the full melanocortin receptor family with particular emphasis on pigmentation biology.

Storage & Handling

MT-2’s cyclic structure provides enhanced stability compared to linear peptides, but proper handling remains important:

• •Storage: Lyophilized MT-2 should be stored at −20°C. The cyclic structure provides some protection against degradation, but long-term stability is best maintained at frozen temperatures.
• •Reconstitution: Use bacteriostatic water. MT-2 dissolves readily due to its relatively small size and cyclic conformation. Gentle swirling is sufficient.
• •Post-reconstitution: Refrigerate at 2–8°C and use within 30 days. The norleucine substitution provides resistance to oxidative degradation, but standard cold-chain practices should still be observed.
• •Light protection: While MT-2 itself is not directly photosensitive, standard practice recommends protection from prolonged UV or direct light exposure during storage.

Conclusion

Melanotan 2 remains one of the most widely studied synthetic melanocortin peptides, offering researchers a tool to investigate the full spectrum of melanocortin receptor biology. From the detailed molecular mechanisms of melanogenesis and MC1R signaling to the broader implications of MC3R, MC4R, and MC5R activation, MT-2 provides a versatile research compound backed by decades of published preclinical and pharmacological data.

For researchers investigating pigmentation biology, melanocortin receptor pharmacology, or the structural basis of peptide–receptor interaction, MT-2 offers a well-characterized starting point with extensive literature to guide experimental protocols.